The Effectiveness and Safety of the Duodenal-Jejunal Bypass Liner (DJBL) for the Management of Obesity and Glycaemic Control: a Systematic Review and Meta-Analysis of Randomized Controlled Trials

Imagem de Miniatura
Arquivos
art_YVAMOTO_The_Effectiveness_and_Safety_of_the_DuodenalJejunal_Bypass_2023.PDF (3.03 MB)
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
SANCHEZ-LUNA, Sergio A.
Citação
OBESITY SURGERY, v.33, n.2, p.585-599, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction The duodenal-jejunal bypass liner (DJBL) is a less-invasive treatment of obesity and type 2 diabetes mellitus (T2DM). Methods This is a systematic review and meta-analysis including randomized clinical trials (RCTs) comparing DJBL versus sham or pharmacotherapies aiming to evaluate the effectiveness and safety of DJBL. Results Ten RCTs (681 patients) were included. The DJBL group showed superior excess weight loss (+ 11.4% [+ 7.75 to + 15.03%], p < 0.00001) and higher decrease in HbA1c compared to the control group (- 2.73 +/- 0.5 vs. - 1.73 +/- 0.4, p = 0.0001). Severe adverse events (SAEs) occurred in 19.7%. Conclusion The DJBL did not reach the ASGE/ASMBS thresholds for the treatment of obesity. However, it is important to state that many SAEs were not really severe. Therefore, we believe this therapy plays an important role in the management obesity and T2DM.
Palavras-chave
Endoscopy, Duodenal-jejunal bypass liner, Obesity, Diabetes, Weight Loss, Glycaemic control, Bariatric surgery, Meta-analysis, Systematic review
URI
https://observatorio.fm.usp.br/handle/OPI/57738
Referências
  1. Abu Dayyeh BK, 2015, GASTROINTEST ENDOSC, V82, P425, DOI 10.1016/j.gie.2015.03.1964
  2. ASGE/ASMBS Task Force on Endoscopic Bariatric Therapy, SURG OBES RELAT DIS, V7, P672
  3. Benes M, 2019, DUODENOJEJUNAL BYPAS, DOI [10.1055/s-0039-1681326, DOI 10.1055/S-0039-1681326]
  4. Betzel B, 2017, SURG ENDOSC, V31, P2881, DOI 10.1007/s00464-016-5299-6
  5. Caiazzo R, 2020, ANN SURG, V272, P696, DOI 10.1097/SLA.0000000000004339
  6. Cambi MPC, 2021, OBES SURG, V31, P1290, DOI 10.1007/s11695-020-05164-1
  7. Colquitt JL, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub4
  8. Condello G, 2020, OBES RES CLIN PRACT, V14, P504, DOI 10.1016/j.orcp.2020.09.001
  9. de Jonge C, 2016, OBES SURG, V26, P672, DOI 10.1007/s11695-015-1889-y
  10. de Jonge C, 2014, OBES SURG, V24, P337, DOI 10.1007/s11695-013-1154-1
  11. de Jonge C, 2013, OBES SURG, V23, P1354, DOI 10.1007/s11695-013-0921-3
  12. de Moura Eduardo G H, 2015, Surg Technol Int, V26, P115
  13. Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae
  14. Gersin KS, 2010, GASTROINTEST ENDOSC, V71, P976, DOI 10.1016/j.gie.2009.11.051
  15. Glaysher MA, 2021, CLIN NUTR, V40, P2343, DOI 10.1016/j.clnu.2020.10.026
  16. Gupta P Sen, 2016, REPORT NO 569
  17. Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD
  18. de Moura EGH, 2015, OBES SURG, V25, P1618, DOI 10.1007/s11695-015-1594-x
  19. Hozo SP, 2005, BMC MED RES METHODOL, V5, DOI 10.1186/1471-2288-5-13
  20. Jirapinyo P, 2018, DIABETES CARE, V41, P1106, DOI 10.2337/dc17-1985
  21. Jung SH, 2020, ENDOSCOPY, V52, P940, DOI 10.1055/a-1149-1862
  22. Kaválková P, 2016, J ENDOCRINOL, V231, P11, DOI 10.1530/JOE-16-0206
  23. Khalafallah A, 2010, MEDITERR J HEMATOL I, V2, DOI [10.4084/MJHID.2010.005, 10.1136/bmj.l4898]
  24. Koehestanie P, 2014, ANN SURG, V260, P984, DOI 10.1097/SLA.0000000000000794
  25. Koehestanie P, 2014, ENDOSC INT OPEN, V2, pE21, DOI 10.1055/s-0034-1365222
  26. Manyika J, 2014, Overcoming obesity: An initial economic analysis
  27. Mechanick JI, 2019, ENDOCR PRACT, V25, P1346, DOI 10.4158/GL-2019-0406
  28. Na HK, 2021, CLIN ENDOSC, V54, P25, DOI 10.5946/ce.2021.021
  29. Nass KJ, 2022, GASTROINTEST ENDOSC, V95, P1078, DOI 10.1016/j.gie.2021.11.038
  30. Nguyen NT, 2011, J AM COLL SURGEONS, V213, P261, DOI 10.1016/j.jamcollsurg.2011.04.030
  31. Rodriguez L, 2009, DIABETES TECHNOL THE, V11, P725, DOI 10.1089/dia.2009.0063
  32. Roehlen N, 2020, OBES SURG, V30, P1200, DOI 10.1007/s11695-019-04324-2
  33. Rohde U, 2016, DIABETES OBES METAB, V18, P300, DOI 10.1111/dom.12603
  34. Rohde U, 2017, DIABETES OBES METAB, V19, P189, DOI 10.1111/dom.12800
  35. Ruban A, 2020, EFFICACY MECH EVALUA, V7, P1, DOI 10.3310/EME07060
  36. Ruban A, 2022, ANN SURG, V275, P440, DOI 10.1097/SLA.0000000000004980
  37. Schouten R, 2010, ANN SURG, V251, P236, DOI 10.1097/SLA.0b013e3181bdfbff
  38. Stratmann B, 2016, HORM METAB RES, V48, P630, DOI 10.1055/s-0042-115175
  39. Tarnoff M, 2009, SURG ENDOSC, V23, P650, DOI 10.1007/s00464-008-0125-4
  40. Tatarian T, 2020, CURR PROB SURG, V57, DOI 10.1016/j.cpsurg.2020.100742
  41. Tripolt NJ, 2019, DIABETES THER, V10, P299, DOI 10.1007/s13300-018-0540-z
  42. U.S. Food & Drugs Administration, 2019, DISC PAP CONS BEN RI
  43. Vilarrasa N, 2017, OBES SURG, V27, P569, DOI 10.1007/s11695-016-2311-0
  44. World Obesity Federation, Prevalence of Obesity

Coleções
Artigos e Materiais de Revistas Científicas - HC/Outros
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/35
Artigos e Materiais de Revistas Científicas - LIM/47
Artigos e Materiais de Revistas Científicas - ODS/03